FIRDAPSE Trademark
FIRDAPSE is a USPTO trademark filed by SERB. Status: Registered.
Prosecution Summary
Trademark Summary
The standard character mark FIRDAPSE covers pharmaceutical preparations for the treatment of autoimmune, neurological, muscular, neuromuscular and cancer-associated diseases and disorders in International Class 005. It is registered on the Principal Register (Reg. No. 4700764) and renewed as of July 30, 2025. Current owner is SERB, a Belgian corporation that acquired the mark via assignment from BIOMARIN PHARMACEUTICAL INC. in 2020.
Recent Activity
Filed October 4, 2013, the mark was published for opposition March 25, 2014, and registered March 10, 2015, after statement of use. On July 30, 2025, Sections 8 and 9 were accepted, renewing the registration for ten years.
Trademark Facts
| Mark | FIRDAPSE |
|---|---|
| Serial Number | 86082826 |
| Registration Number | 4700764 |
| Status | Registered |
| Filing Date | 2013-10-04 |
| Registration Date | 2015-03-10 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | SERB |
| Attorney of Record | Brooks R. Bruneau |
| Prosecution Events | 41 |
| Latest Event | NA89 on 2025-07-30 |
Goods & Services
Pharmaceutical preparations for the treatment of autoimmune, neurological, muscular, neuromuscular and cancer-associated diseases and disorders